Maxigen Biotech Inc. announced the appointment of Lin Yung-Hsiang, Liao Sung-Yuan, Li Shi Ming, Zeng Zhong Ming and Chen Ching-Ting to the newly formed risk management committee effective as on May 3, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42.25 TWD | +0.12% | -0.24% | -12.71% |
1st Jan change | Capi. | |
---|---|---|
-12.71% | 116M | |
+20.57% | 20.37B | |
0.00% | 19.29B | |
+17.45% | 12.64B | |
-16.59% | 8.94B | |
+33.93% | 8.62B | |
+9.55% | 5.93B | |
-11.66% | 3.92B | |
-15.51% | 3.84B | |
-0.80% | 3.77B |
- Stock Market
- Equities
- 1783 Stock
- News Maxigen Biotech Inc.
- Maxigen Biotech Inc. Appoints Members of the Company's Risk Management Committee